The FRAP (Ferric Reducing Antioxidant Power) test system [24] was used to determine AOA. Briefly, 60 μL of plasma or cytosolic fraction of liver was added to 1.80 mL of the reaction mixture, consisting of 0.83 mM 2,4,6-tripyridyl-s-triazine and 1.67 mM FeCl3 × 6H2O in 0.25 M acetate buffer (pH 3.6) with subsequent measurement of the change in absorption at 593 nm for 4 min.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.